Issues
Today’s addition is a profitable small-cap MedTech company specializing in products to treat peripheral nerve injuries.
Management has a number of growth-oriented irons in the fire. And I think the company could be an attractive acquisition target.
While the sock has been relatively stable in this increasingly volatile market, we’ll still start with a half-sized position, just in case.
Management has a number of growth-oriented irons in the fire. And I think the company could be an attractive acquisition target.
While the sock has been relatively stable in this increasingly volatile market, we’ll still start with a half-sized position, just in case.
Updates
The S&P 600 SmallCap Index is flat over the last week.
The upside move from the extreme oversold conditions that began two weeks ago has faded as the market grapples with tariff uncertainty.
Uncertainty will continue to linger even though Trump clarified part of his tariff plan last night through an executive order imposing permanent tariffs on autos not produced in the U.S.
The upside move from the extreme oversold conditions that began two weeks ago has faded as the market grapples with tariff uncertainty.
Uncertainty will continue to linger even though Trump clarified part of his tariff plan last night through an executive order imposing permanent tariffs on autos not produced in the U.S.